<DOC>
	<DOCNO>NCT01201187</DOCNO>
	<brief_summary>This study evaluate clinical efficacy safety treatment YY-162 child ADHD</brief_summary>
	<brief_title>Efficacy Safety Study Combination Ginkgo Extract Ginseng Extract ( YY-162 ) Children With ADHD</brief_title>
	<detailed_description>This Double-Blind , two arm , multi-center , Interventional , 8 week study start YY-162 ( Combination Ginkgo extract Ginseng extract child ADHD . Assessment efficacy safety perform baseline , week 2,4 , 8 . At first visit , full psychiatric history , demographic date physical examination undertaken . Throughout study , follow procedure , documentation evaluation perform ; K-ARS , IOWA Conner 's rating scale , CGI-S/I , ATA , Children 's color trail test stroop test , Intelligence test ( KEDI-WISC ) adverse event reporting .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Male female subject age 6 12 Subjects must meet DSMIV criterion ADHD basedon KSchedule affective disorder schizophrenia ( KSADSPLK ) interview Subjects sign write consent form voluntarily . Patient 's assent participate study write informed consent form sign one parent , parent surrogate , legal guardian . Subjects keep visit schedule whose parent/ parent surrogates legal guardian willingly complete assessment define study protocol Subjects/parents , parent surrogate legal guardian understand participation study voluntarily withdraw study time Subjects difficulty swallow tablet . Subjects know allergy plant extract . Subjects meet DSMIV diagnostic criterion current major depressive disorder anxiety disorder require drug therapy . Subjects history bipolar disorder , psychotic disorder , substance use disorder , diagnose pervasive developmental disorder , organic brain disease seizure disorder . Subjects significant suicidal ideation . Subjects mental retardation Subjects Tourette 's syndrome require drug therapy . Subjects administrate Methylphenidate Atomoxetine within recent 3 month Ginkgo extract Ginseng extract within recent 1 month . Subjects currently significant medical condition ( e.g . disease cardiovascular , hepatic , renal , respiratory , glaucoma ) . Subjects abnormality ECG show clinically significant abnormality laboratory result , include serum chemistry hematology . Subjects currently take alpha2 adrenergic receptor agonist , antidepressant , antipsychotic , benzodiazepine , modafinil , anticonvulsant Subjects receive psychosocial treatment drug trial . Subjects able swallow study drug .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ADHD ( Attention Deficit Hyperactivity Disorder )</keyword>
</DOC>